NDC 73606-010 – Empaveli

Pegcetacoplan 1080 mg/20mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC73606-010

Product details

Brand name
Empaveli
Generic name
Pegcetacoplan
Labeler
Apellis Pharmaceuticals, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA215014
Marketed since
May 14, 2021
Listing expires
December 31, 2027
Pharmacologic class
Complement Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Empaveli →

Package NDC codes (1)

Package NDCDescriptionSince
73606-010-011 VIAL in 1 CARTON (73606-010-01) / 20 mL in 1 VIALMay 14, 2021